Kazakhstan to use U.S. produced vaccine against HPV

In Kazakhstan, cervical cancer is the second most prevalent cancer among Kazakhstani women after breast cancer,El.kz reports.

Vaccination is the only way of preventing the human papilloma virus infection and spread of cervical cancer.

According to the Committee of the Ministry of Health, there are three HPV vaccines: bivalent, quadrivalent and nine-valent.

These vaccines are highly immunogenic and administered intramuscularly, allowing rapid access to draining lymph nodes. Vaccines also contain adjuvants that help activate a strong humoral response and create a robust immune memory.

In Kazakhstan, for vaccination against the HPV, the quadrivalent Gardasil vaccine, produced in the U.S., will be used, which protects against the most oncogenic types of HPV - 6, 11, 16 and 18..

351.8 thousand doses of HPV vaccine were purchased. Vaccination will help improve the health of the population as a whole, as well as reduce morbidity and mortality from cancer.

The minimal risks associated with vaccination are completely leveled when compared with the health risks in the case of non-vaccination.

Subscribe to our Telegram channel and be the first to know the news!